Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

DELCATH SYSTEMS, INC. (DCTH) Cash Flow Statement

DELCATH SYSTEMS, INC. (DCTH) generated $19.6M of operating cash flow over the twelve months to 2026-06-30, spent $2.1M on capital expenditure and had free cash flow of $17.5M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

DCTHDELCATH SYSTEMS, INC.Follow DCTH — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
500.4M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
10 Nov, in 17 days
LineFY2012
Dec 12
FY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-50.0-34.1-15.6-16.4-25.0-31.3-18.722.519.6
Capital expenditure2.10.10.00.20.20.10.61.5-2.1
Free cash flow-52.1-34.2-15.6-16.6-25.2-31.3-19.221.017.5
Share repurchases——————0.06.0—

USD millions · SEC XBRL

DELCATH SYSTEMS, INC. — questions

What is DELCATH SYSTEMS, INC.'s operating cash flow?
$19.6M over the twelve months to 2026-06-30.
How much does DELCATH SYSTEMS, INC. spend on capital expenditure?
$2.1M over the twelve months to 2026-06-30.
What is DELCATH SYSTEMS, INC.'s free cash flow?
$17.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from DELCATH SYSTEMS, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.